ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Iovance Biotherapeutics Inc

Iovance Biotherapeutics Inc (2LB)

8.702
0.066
( 0.76% )
Updated: 05:17:43
Realtime Data

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 171.89M155.37M480.82M344.66M768.46M777.33M663.98M780.35M
Total Current Assets 169.51M149.29M475.37M316.49M636.1M507.96M479.12M307.85M
Cash and Equivalents 106.72M145.37M82.15M13.97M67.33M78.23M231.73M114.89M
Total Non-Current Assets 166.92M145.48M466.19M298.97M656.5M621.66M499.64M584.61M
Total Liabilities 4.97M9.89M14.63M45.68M111.96M155.67M164.34M195.74M
Total Current Liabilities 4.97M9.89M14.4M39.08M54.87M89.2M91.49M110.31M
Total Non-Current Liabilities 00230k6.6M57.09M67.47M73.86M86.43M
Total Equity 166.92M145.48M466.19M298.97M656.5M621.66M499.64M584.61M
Common Equity 11k10k11k9k10k10k11k14k
Retained Earnings -157.12M-249.18M-372.76M-570.61M-830.19M-1.17B-1.57B-2.01B